PulseAugur
EN
LIVE 11:49:44
中文(ZH) 复宏汉霖在南京成立新生物技术公司，注册资本5000万

Fuhong Hanlin launches new Nanjing biotech subsidiary

By PulseAugur Editorial · [1 sources] ·

Fuhong Hanlin has established a new biotechnology company in Nanjing, China, with a registered capital of 50 million RMB. The company, named Fuhong Hanlin (Nanjing) Biotechnology Co., Ltd., is wholly owned by Fuhong Hanlin and will focus on technology services, development, consulting, exchange, transfer, and promotion. AI

RANK_REASON The cluster describes the establishment of a new subsidiary, which is a business operation rather than a core AI development.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Fuhong Hanlin launches new Nanjing biotech subsidiary

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster describes the establishment of a new subsidiary, which is a business operation rather than a core AI development.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
104 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Fuhong Hanlin establishes a new biotechnology company in Nanjing with a registered capital of 50 million

    36氪获悉，天眼查App显示，近日，复星汉霖（南京）生物技术有限公司成立，法定代表人为余诚，注册资本5000万人民币，经营范围为技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广，由复宏汉霖全资持股。

RELATED ENTITIES

RELATED TOPICS